Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Cash from Investing Activities: 2011-2024

Historic Cash from Investing Activities for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to -$9.6 million.

  • Mimedx Group's Cash from Investing Activities fell 4753.10% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year decrease of 27.70%. This contributed to the annual value of -$9.6 million for FY2024, which is 344.69% down from last year.
  • As of FY2024, Mimedx Group's Cash from Investing Activities stood at -$9.6 million, which was down 344.69% from -$2.2 million recorded in FY2023.
  • Over the past 5 years, Mimedx Group's Cash from Investing Activities peaked at -$2.2 million during FY2023, and registered a low of -$9.6 million during FY2024.
  • In the last 3 years, Mimedx Group's Cash from Investing Activities had a median value of -$2.7 million in 2022 and averaged -$4.8 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 1,003.77% in 2020, then rose by 25.47% in 2021.
  • Mimedx Group's Cash from Investing Activities (Yearly) stood at -$4.6 million in 2020, then increased by 25.47% to -$3.4 million in 2021, then rose by 21.65% to -$2.7 million in 2022, then increased by 18.98% to -$2.2 million in 2023, then plummeted by 344.69% to -$9.6 million in 2024.